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Abstract
Alarm substances are airborne chemical signals, released by an individual into the environment, which communicate
emotional stress between conspecifics. Here we tested whether humans, like other mammals, are able to detect emotional
stress in others by chemosensory cues. Sweat samples collected from individuals undergoing an acute emotional stressor,
with exercise as a control, were pooled and presented to a separate group of participants (blind to condition) during four
experiments. In an fMRI experiment and its replication, we showed that scanned participants showed amygdala activation in
response to samples obtained from donors undergoing an emotional, but not physical, stressor. An odor-discrimination
experiment suggested the effect was primarily due to emotional, and not odor, differences between the two stimuli. A
fourth experiment investigated behavioral effects, demonstrating that stress samples sharpened emotion-perception of
ambiguous facial stimuli. Together, our findings suggest human chemosensory signaling of emotional stress, with
neurobiological and behavioral effects.
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Introduction
The existence of alarm substances in communicating emotional
stress via chemosensory cues is well-established in mammals [1], with
animals exposed to odors secreted by acutely stressed conspecifics
expressing neurobiological and behavioral changes consistent with
increased arousal and threat-assessment [2–4]. In recent years, a
significant body of research has explored the role of human
chemosensory signals for reproductive function, an area that is
controversial [5] but which appears to provide some evidence for
influence on humans in some of the same contexts in which they exist
for non-human mammals [6–18]. This conservation across species is
biologically suggestive, and predicts that human chemosensory signals
for emotional stress may also exist and assume functional importance.
To date, six studies worldwide have published reports on human
stress signaling via sweat. Twostudies [19,20]found that individuals
were able to identify, solely by smelling sweat collected on axillary
pads, whether the sweat donor had been watching a frightening
versus benign film. Using a similar collection paradigm with
frightening and benign films, one study [21] found that participants,
when smelling the stress, but not neutral, sweat showed improved
accuracy in completing a word-association task, while another [22]
found that stress sweat caused participants to interpret ambiguous
expressions as more fearful. Two studies collected sweat from
individuals preparing to take a difficult examination with exercise
sweat as the control. In one study, females exposed to the stress odor
were less likely to judge a face as positive when primed with a
positive face [23], while in the other, auditory stimuli provoked an
increased startle response [24] when participants breathed sweat
collected during the stress condition.
We set out to determine whether breathing the sweat of people
who were emotionally stressed produced, in a group of unrelated
individuals, neurobiological evidence of emotion-perception. The
primary area associated with emotion-processing is the amygdala
[25,26], which has been reliably activated in human neuroimaging
studies of emotion [27] as well as animal studies using rat alarm
substances [3].
To obtain human sweat stimuli, we first collected axillary samples
obtained from 144 individuals participating in a stress condition (first-
time tandem skydive) and a control condition (running on a treadmill
for the same duration of time at the same time of day). Sweat donors
jumped from 4 km (13,000 ft.), with one full minute of free-fall at a
vertical speed of 193 km/hr and four minutes under the parachute.
Because the tandem-master controlled the descent, the skydiving
condition produced a predominantly emotional but not physical
stressor for our sweat donors, while the exercise condition produced a
predominantly physical but not emotional stressor. Significant
increases in both participant cortisol-levels (repeated-measures AN-
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anxiety (paired t-test: t=10.02, p=0.000, N=40), confirmed that the
paradigm was successful at inducing emotional stress. The sweat
collection and storage protocols were designed to prevent bacterial
growth, which gives otherwise odorless sweat its characteristic aversive
odor.
Axillary samples, once extracted and pooled for each condition,
were then used as stimuli for four experiments. Two fMRI
experiments assessed amygdala activation as well as possible gender
interactions that could indicate confounds due to reproductive
chemosignals, which have been shown to be sex-specific [13]. The
amygdalais notonlyassociatedwithemotion, but also plays akey role
in olfactory processing [28]. To confirm that test and control
conditions differed only with respect to emotion, and not perceivable
odor, we used a double-blind forced-choice discrimination task, as
well as Likert scales, to verify that participants were unable to detect
intensity, valence, or qualitative differences in odor between the stress
and exercise sweat. Finally, we tested the behavioral implications of
the amygdala activation, to investigate how stress sweat affects threat-
perception using psychometric curves generated by participants’
responses to morphed neutral-to-threatening faces.
Participants for all experiments were screened for anosmia prior
to testing. For the fMRI and behavioral experiments, presentation
of sweat extracts was controlled with synchronized nasal inhalation
(Figure 1); for the odor discrimination experiments, individuals
were asked to sniff the sample.
Results
fMRI Experiments
In the original experiment, we presented sweat from 40 male
donors to 16 participants (50% female) while their brains were
scanned using fMRI. In a replication experiment, using different
participants and scanners, we presented sweat from an additional 40
donors (50% female) to a different group of 16 participants (50%
female) undergoing fMRI, increasing power by doubling the number
of stimulus presentations. Because we hypothesized that perception of
emotional stress would modulate activity in a brain area related to
emotion, our analyses focused on the amygdala; all values were
corrected for multiple-comparisons using small-volume correction
(SVC). For both experiments, these revealed significant activation of
the left amygdala (Original Experiment: t=4.80/Z=3.68, p(svc)=0.02
[MNI x, y, z=216, 210, 218], N=16; Replication Experiment:
t=5.21/Z=3.88, p(svc)=0.008, [MNI x, y, z=227, 26, 212],
N=16; Figure 2) in response to the stress sweat as compared to the
exercise sweat. For both experiments, activity was concentrated most
strongly in the superficial, or corticoid, amygdala (Original Experiment:
t=4.80/Z=3.68, p(svc)=0.008, N=16; Replication Experiment: t=5.21/
Z=3.88, p(svc)=0.008, N=16)—a region known to have substantial
olfactory inputs in primates; homologous structures in other mammals
have been implicated in pheromonal processing [29]. Activation
patternswere equivalentforsame-sexand opposite-sexdonor-detector
pairs (repeated-measures ANOVA: Original Experiment: F=1.76,
p=0.21, N=16; Replication Experiment: Donor Sex: F=0.21, p=0.65,
N=16;Detector Sex: F=1.31, p=0.27, N=16; Donor Sex*Detector Sex:
F=0.004, p=0.952, N=16), suggesting that reproductive chemo-
signals, known to be sex-specific in both animals [30] and humans
[13], were not the likely cause. Whole-brain random-effects analyses
for the STRESS-EXERICISE contrast (Figure 3, Table 1) included
the amygdala with no significant de-activations.
Odor Perception Experiments
While the fMRI experiments indicate that participants’amygdala
were able to distinguish between the sweat of stressed and non-
stressed colleagues, it was important to establish whether this
activation might be attributable to odor differences between the two
Figure 1. During the fMRI scans, participants’ breathing was synchronized via a continuously expanding and contracting circle (a),
which cued inhalation and exhalation, respectively. Stress and exercise sweat were presented in a randomized block design, with each 20s
block comprised of four inhalations-exhalations (b), timed to a five-second cycle.
doi:10.1371/journal.pone.0006415.g001
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using Likert scales ranging from zero (‘‘undetectable’’/‘‘pleasant’’)
to ten (‘‘very strong’’/‘‘unpleasant’’) as equivalently mild (Stress:
m=2.6, s.d.=2.3, Exercise: m=2.6, s.d.=2.3; Wilcoxon sign-ranks
test:Z=1.11,p=0.28,N=26)and neutral(Stress:m=4.5, s.d.=1.1,
Exercise: m=4.8, s.d.=0.8; Wilcoxon sign-ranks test: Z=1.56,
p=0.12, N=26). To investigate whether the conditions had odors
that were qualitatively distinct, we also conducted a double-blind
forced-choice odor discrimination experiment, in which 16
participants (50% female) identified whether 16 test and control
pairs (50% different), randomly presented, were identical or
different; participant ratings were not significantly different than
chance (one-sample t-test: t=0.64, p=0.53, N=16). The data
suggest that participants were not able to consciously distinguish
between test and control odors, and therefore rule out simple odor
discrimination as an explanation for amygdala activation in
response to the STRESS2EXERCISE contrast.
Threat-Perception Experiment
Since data from our two previous experiments suggested that
the observed amygdala activation reflected emotion discrimination
rather than odor discrimination, we then tested whether breathing
stress sweat vs. exercise sweat from 64 donors (50% female)
behaviorally affected perception of subtle emotional cues in the
evaluation of ambiguous faces. Psychometric curves [33] were
generated from a forced-choice design in which 14 participants
(36% female) indicated via a computer mouse whether briefly-
presented (200 ms) male faces, morphed between neutral and
angry expressions, were ‘‘more neutral’’ or ‘‘more threatening.’’
For each participant, stress and exercise conditions produced
psychometric curves, each composed of nine points ranging from
neutral (10%) to angry (90%), with each point the average of 14
face presentations. Threat-levels were presented randomly, with
experimental conditions counter-balanced for order. Values for
slope, s, were calculated for each curve using sigmoidal fitting.
These showed sharpened discrimination (mean 43% increase)
between neutral versus angry faces in response to the stress sweat
(Stress: s=0.192, s.d.=0.101; Exercise: s=0.134, s.d.=0.066;
repeated-measures ANOVA: F=8.30, p=0.01, N=14,
Figure 5b). No differences between conditions were observed for
inflection-points (F=1.35, p=0.27, N=14), suggesting that the
effect was specific to reducing perceptual noise and thereby
increasing accuracy in the evaluation of ambiguous threat, rather
than to the attribution of threat to neutral stimuli.
Figure 2. Breathing stress-derived sweat modulates the amygdala, the primary brain region associated with emotional processing.
The unmasked activation map (a) reflects the STRESS2EXERCISE contrast, and was produced using height threshold t=3.7, p,0.001 (uncorrected)
and extent threshold k=5 voxels. The MNI coordinates of the maximally activated voxel, located in the left amygdala, are [x=227, y=26, z=212]
(t=5.21/Z=3.88; p(small-volume-corrected)=0.008). Inspection of the mean response to STRESS-REST and EXERCISE-REST contrasts (b) initially appeared to
suggest mean deactivation in response to EXERCISE sweat. However, once we factored in the variance (c), it became clear that the effect for the
STRESS-EXERICISE contrast was predominantly due to activation in response to the STRESS condition, rather than to deactivation in response to the
EXERCISE condition, as only the former showed statistically significant changes from baseline.
doi:10.1371/journal.pone.0006415.g002
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de-activations (EXERCISE.STRESS) in cool colors, showed that differences between the two conditions were most pronounced in
the amygdala, with no significant de-activations. These images were produced at p,0.005, with extent threshold=5 voxels. Table 1 provides a
list of all significantly activated clusters corresponding to this whole-brain random-effects analysis.
doi:10.1371/journal.pone.0006415.g003
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While it is commonly known that information regarding the
emotional stress of others is communicated in humans by visual
and auditory cues, our findings suggest that humans—like other
mammals—may complement this information with chemosensory
cues as well. Sweat collected during an acute emotional stressor,
and subsequently presented to an unrelated group of individuals,
produced significant brain activation in regions responsible for
emotional processing without conscious perception of distinct
odor; behavioral data, our own as well as those from previous
studies, suggest the emotional processing may be specific to
enhancing vigilance and sharpening threat-discrimination.
Our hypothesis and analyses targeted the amygdala, given its
critical role in emotion processing; however, areas associated with
vision, motor control, and goal-directed behavior also activated in
response to the stress sweat. Previous research has established that
emotional stimuli not only activate areas of the brain associated
specifically with emotion-perception, but also activate sensory
areas associated with perception of concomitantly-presented
stimuli [34]; this is thought to reflect the increased salience
attached to stimuli perceived within emotional contexts. We
therefore suspect that increased activation within the cerebellum,
BA7, and BA20 most likely resulted from participants‘ enhanced
perception during the stress condition of the visual breathing cues
(Figure 1a), which required timing inhalation and exhalation to the
motion of expanding and contracting rings throughout the
experiment.
Because this was the first neuroimaging study to investigate
chemosensory cues to emotional stress, we were careful to
rigorously control for a number of potential confounds, both
methodological and conceptual. Bacterial contamination of sweat
contributes to its strong aversive odor; therefore, we developed
sample collection methods that would keep the samples as sterile as
possible while still preserving chemical components of interest in
apocrine sweat. These were validated using gas chromatography-
mass spectroscopy (see Materials and Methods). To ensure that
differences observed between the two conditions were not due to
differences in participant compliance in following the synchro-
nized cues, we also analyzed trial-specific respiratory parameters
for the first experiment (see Materials and Methods) and closely
monitored participants’ respiration in real-time during each
subsequent experiment. The lack of donor sex-detector sex
interactions suggests that the effect is unlikely to be consequent
to reproductive pheromones released during either of the two
conditions. This is a critical point, since a serious limitation of
previous studies using stress sweat was the tendency to use male
donors and female detectors, which made it impossible to identify
sex-effects or eliminate reproductive pheromones as possible
confounds to the effect. Finally, replication of the neurobiological
findings across two independent fMRI studies with different donor
and detector participants suggests the effect is robust to individual
variability.
The mean percentage signal change values (Figure 2b) initially
appeared to suggest that, as much as stress sweat increased
amygdala activity from baseline, exercise sweat reduced it from
baseline; therefore, the effect might have been inflated by our
choice of a control condition (although using AIR as a control
condition would have been even more problematic since AIR,
unlike EXERCISE, would not have controlled for sweat odor).
However, statistical analyses that consider the variance (Figure 2c)
make clear that it was the STRESS condition, and not the
EXERCISE condition, that was primarily responsible for the
STRESS-EXERCISE effect. For the original fMRI study, the
change for STRESS—REST was statistically significant or trend,
whether it was calculated using the maximally-activated voxel
(t=1.88/Z=1.76, p=0.04, N=16), ROI analysis for the
superficial amygdala (t=1.48/Z=1.41, p=0.08, N=16), or
ROI analysis for the whole amygdala (t=1.65/Z=1.55,
p=0.06, N=16). However, for the EXERCISE-REST contrast,
none of the three was statistically significant (for SVC maximally-
activated voxel: t=21.61/Z=20.27, p=0.61, N=16; for the
superficial amygdala ROI: t=20.52/Z=0.52, p=0.30, N=16;
for the left amygdala ROI: t=0.30/Z=0.31, p=0.38, N=16).
Exactly the same pattern held for the replication study. Here, the
change for STRESS—REST was even stronger, whether it was
calculated it using the maximally-activated voxel (t=3.69/
Z=3.06, p=0.001, N=16), ROI analysis for the superficial
amygdala (t=3.23/Z=2.75, p=0.003, N=16), or ROI analysis
for the whole amygdala (t=2.58/Z=2.29, p=0.01, N=16).
However, for the EXERCISE-REST contrast, again none of the
three was statistically significant (for SVC maximally-activated
voxel: t=21.43/Z=20.25, p=0.59, N=16; for the superficial
amygdala ROI: t=0.36/Z=0.35, p=0.36, N=16; for the left
amygdala ROI: t=0.67/Z=0.66, p=0.26, N=16). Since both
original and replication studies show significant differences for the
STRESS-REST contrasts, but not for the EXERCISE-REST
contrast, it is clear that results obtained for the STRESS-
EXERCISE contrast were not driven by participants’ responses
to the EXERCISE sweat.
The behavioral effect of the STRESS sweat was to sharpen
emotional discrimination, rather than to lower thresholds for
attribution of threat. Our findings are in line with more recent
conceptualization of the amygdala’s role, in which the amygdala
appears to be not simply a marker for fear, but rather involved in
evaluating stimuli for potential threat and then coordinating
appropriate responses via its cortical feedback connections (see, for
example, [35]). The latter view is consistent with a wide range of
fMRI results: for example, the amygdala is activated during
conditioning to pain [36–38], anticipation of potential pain ([39]
Table 1. Results of exploratory (random-effects) analysis of STRESS2EXERCISE sweat for replication fMRI study: height threshold
T=3.7 (puncorrected,0.001), extent-threshold=5 voxels.
MNI Coordinates (x,y,z) Region k T/Z Score p(uncorr) Associated Functions
221,3,215 Left Amygdala 10 6.19/4.30 0.000 Emotion
29, 233, 224 Left Cerebellum, Anterior Lobe 7 5.70/4.10 0.000 Integration of sensory perception and motor control
57, 224, 230 Right Inferior Temporal Gyrus (BA20) 6 4.59/3.57 0.000 Visual processing
12,254,54 Right Precuneus (BA7) 5 4.53/3.54 0.000 Spacial reference system for goal-oriented behavior
There were no significant de-activations.
doi:10.1371/journal.pone.0006415.t001
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response to social cues to potential threat, such as the aversive
outcomes implied by fearful faces [27] but not to unambiguously
threatening stimuli such as the object of phobias [43,44]. As such,
one would expect that a chemosensory cue that facilitates the
evaluation and discrimination of threat from non-threat would
also activate the amygdala, as well as lowering sensory gating for
olfactory, visual, and auditory cues that might further inform risk-
assessment.
One potential limitation of our study design was that we
morphed between only two facial expressions (fear versus neutral);
therefore, our study could not confirm whether the sharpened
discrimination that we observed extended to all emotional
expressions or was restricted specifically for threat. However,
results obtained by a recent study [22] argue against generaliza-
tion. Asked to distinguish between ‘‘happy’’ and ‘‘fearful,’’ in a
design similar to ours using morphed facial expressions, partici-
pants rated ambiguous faces as ‘‘fearful’’ more frequently in the
context of stress sweat, thereby lowering thresholds for detecting
fear in others rather than sharpening discrimination. These results
suggest that angry and fearful faces communicate distinct types of
information that may interact with chemosensory stress cues in
complementary ways. Angry faces represent a direct threat, and
therefore detection of an anxious colleague’s alarm cues may elicit
Figure 4. On Likert Scales, participants rated both conditions as mild and neutral; there were no significant differences between
their ratings between conditions. A separate forced-choice discrimination experiment additionally indicated that participants were unable to
distinguish between the two odors. Together, these suggest that the amygdala activation seen in response to the STRESS, but not EXERCISE, sweat
was due to engagement of emotional processing rather than perception of distinct odors.
doi:10.1371/journal.pone.0006415.g004
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danger. In contrast, when asked to identify whether faces are fearful
in the context of stress sweat, participants are essentially
integrating multi-modal sensory cues in detecting colleagues’
anxiety, much as auditory cues such as laughter would bias visual
perception of an ambiguous smiling faces towards ‘‘joy.’’ Future
research, using a within-subjects design, can more directly test this
hypothesis.
Previous protocols have sampled sweat in response to stressors
such as horror films and pre-examination anxiety. These stressors
obviously have the advantage of being easier to administer, but are
quite removed from alarm pheromones’ evolutionary purpose; i.e.,
fear associated with imminent physical danger. We chose to
address this limitation by using first-time tandem skydives, which
have shown to reliably induce acute fear (approaching near-
pathological states and including traumatic psychological symp-
toms such as dissociation, loss of awareness, and time-distor-
tion[45–53]), in an ethically acceptable and scientifically-con-
trolled manner. The endocrine and self-report measures confirm
that the protocol reliably provoked profound emotional stress in
our sweat donors. However, debriefing of our donors and their
tandem-masters post-jump indicated that while fear markedly
increased during the ascent, peaking in the minutes leading up to
exiting the plane and during freefall ($16 minutes), feelings of
relief and/or thrill sometimes followed once the parachute opened
and upon landing (#4 minutes). Donor sweat pads could not be
removed until immediately after landing; therefore, it is theoret-
ically possible that our neurobiological and behavioral results
resulted from chemosignals emitted in response to non-affect-
specific hyper-arousal or thrill, rather than pure fear. However, it
is important to note that while alarm substances are well-
established neurobiologically, behaviorally, and chemically in a
wide number of species, including mammals [54], and therefore
their conservation in humans is a reasonable extension, an
equivalent ‘‘thrill’’ pheromone has never been reported for any
species. Therefore, we believe it is much more likely that
participants excreted an alarm substance during the initial fear
portion of the protocol, which was retained in the sample even in
the face of later relief.
Materials and Methods
All experiments reported in this manuscript were approved by
the Institutional Review Board of Stony Brook University. In
addition, the replication fMRI experiment was approved by the
Institutional Review Board of McLean Hospital; all participants
provided written informed consent.
Methods for Generating Sweat Samples
We recruited 144 participants (‘‘Donors’’), each of whom had
previously contacted Skydive Long Island (Calverton, NY) to
schedule his or her first-time tandem skydive. All participants were
between the ages of 18–50 (m=25; s.d.=6), with a Body Mass
Index,25, free of cardiac illness, and had not skydived before.
Participants wore a digital altimeter (Altimaster Neptune), showing
a consistent rise-time of 15 minutes, jump at 13,000 ft, freefall
lasting 60 seconds, and parachuting for an additional 4 minutes
before landing; this resulted in stress condition of total of 20
minutes (5 minute fall plus 15 minutes of anticipatory anxiety
preceding the jump). Salivary cortisol samples were obtained from
40 of the participants using the passive drool method [55]
immediately prior to take-off (15 minutes prior to the jump) and
again following landing. Cortisol measurements were taken
between 1–7 pm to minimize diurnal variability and assayed
using Salimetrics Salivary Cortisol Kits (Salimetrics, State College
PA). Self-reports of skydiver state anxiety were obtained using the
Spielberger State Anxiety Inventory (Mind Garden Inc., Menlo
Park, CA), 15 minutes prior to the jump as well as 15 minutes
prior to the exercise.
The control condition was conducted on a separate day than the
skydive, within 2 hours of the jump-time. During the control
condition, each sweat donor was instructed to run on a treadmill at
his or her maximum comfortable rate for 20 minutes. We allowed
participants to control their own levels of exertion to ensure
production of sweat without inducing emotional distress. Salivary
samples were obtained immediately prior to start and immediately
Figure 5. Psychometric curves generated by a forced-choice
assessment of ambiguous threat show sharpened discrimina-
tion between threat and non-threat while breathing stress-
derived sweat. For each participant, data for each condition (STRESS,
EXERCISE) were fitted with the sigmoid function, where p0 and p0+Dp
define upper and lower asymptotes, A0 is the inflection point, and s
defines slope. Significant differences between conditions were seen for
slope, with individuals under the STRESS condition more closely
approximating ideal perceptual discrimination, shown by the dotted
line.
doi:10.1371/journal.pone.0006415.g005
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identically to those collected during the stress condition.
For our skydiving condition we deliberately chose to use only
tandem jumps. This meant that the tandem-master took over all
physical aspects of the jump, including stabilization and steering, to
ensure that physiological measures obtained during skydive
condition reflected predominantly emotional, and not physical,
stress. Our donor participants reported a significant increase in state
anxiety (paired t-test: t=10.02,p=0.000,N=40)betweenthe stress
(73
rd percentile rank for males 19–39; m=42, s.d.=11) and exercise
(25
th percentile rank for males 19–29; m=28, s.d.=8) conditions.
MeancortisolvaluesforthestressconditionwerePRE=0.229 mG/
dL (s.d.=0.148) and POST=0.584 mG/dL (s.d.=0.310), and
showed a significant increase (paired t-test: t=7.15, p=0.000,
N=40). Mean cortisol values for the exercise condition were
PRE=0.170 mG/dL (s.d.=0.165) and POST=0.207 mG/dL
(s.d.=0.175); no significant increase was observed (paired t-test:
t=1.40, p=0.17, N=40). We additionally performed a repeated-
measures ANOVA, comparing PRE v. POST increases between
the two conditions. The condition*(PRE, POST) interaction was
significant, with the stress condition producing a significantly larger
increase (PRE, POST) than the exercise condition (F=39.87,
p=0.000, N=40). Thus, using both self-report and physiological
measures we confirmed that skydives were an effective means of
inducing a reliable emotional stress response and that exercise
functioned as an acceptable control condition.
Sweat sample collection methods were identical for test and
control collections. Sweat pads were attached immediately prior to
participants’ boarding and were removed immediately after
landing. The total period of sweat collection, during both skydive
and exercise conditions, was 20 minutes. Potential participants were
excluded from participation in the study if they had used
deodorant/antiperspirant on either day of the sample collection.
Participants first had their underarms closely shaved. Prior to
application of the sweat pads, the participants’ axillary regions were
washed witha non-ionicdetergent (0.1%TritonX-100), rinsedwith
ultra-pure water, dried, and finally, washed with isopropanol.
Axillary sweat was collected on sterile cleaned (washed 2x in
Methanol, 2x in Hexane; both solvents are 99.9% GC
2, Burdick &
Jackson, USA) woven gauze sponges (262’’, Dukal, USA) that were
placed on clean thin mylar squares and taped in the underarm with
waterproof adhesive tape (2’’, HYTAPE, USA). Solvents were fully
evaporated prior to sweat pad construction. After the collection of
the sweat was completed, the sweat pad was removed and
immediately frozen in tightly sealed Teflon-lined and pre-cleaned
borosilicate vials (20 ml, VWR Traceclean, VWR, USA) at 220uC,
until the sweat extraction.
To extract the liquid sweat from the sweat pad, we used salivette
tubes (Sarstedt, Newton, NC), substituting the sweat pad for the
salivette’s absorbent insert. Next, double-distilled water was added
so that the tube insert was completely filled with both water and
the pad. The salivette tubes were placed into an ultrasound bath
for 5 minutes and centrifuged to separate the aqueous sample from
the cotton pad. The samples were separated into two batches of 20
participants each, each batch of which were pooled and diluted to
produce sufficient sample for 8 fMRI experiments. After removal
from the sweat pad, the sweat samples were frozen at 220uC in
18 ml batches (one per experiment) to avoid multiple thaws. Three
hours prior to each fMRI experiment, the samples were thawed at
room temperature.
Validation of Sample Collection Methods
Given that the majority of the compounds detectable in human
sweat are hydrophobic [56,57] but that our method used water to
both remove the sweat and act as a medium to present the sweat
molecules to the participants, we performed gas chromatography
mass spectroscopy as well as calculations using Henry’s law to
ensure that our collection, extraction, and delivery methods were,
in fact, capable of presenting sweat molecules of interest.
Analysis of sweat extracts by Gas Chromatography Mass
Spectroscopy (GCMS). GCMS was performed using a VG
Quattro triple quadrupole mass spectrometer with EI source and
HP5970 gas chromatograph. The samples were taken from males
participating in the exercise condition, and were first prepared as
for the fMRI experiments (extraction into water). We then added
1:20th of GC purity hexane (containing 0.3 ng/ml chrysene-d12
for normalization) to partition volatile and semi-volatile molecules
into the organic phase. Using a syringe, we recovered 350 mlo f
hexane that was then blown down with nitrogen to 35 ml of which
we injected a few ml into the GCMS. We used a 25m DB5 column
for GC. The protocol for GC was as follows: 1) the temperature
was kept at 70C for 5 min; 2) we increased the temperature to
300C ramping by 10 C/min; 3) temperature was kept at 300C for
ten minutes.
A typical total ion count GC trace of our samples is shown in
Figure 6. Cholesterol comes off the column at 32.07 min and
chrysene-d12 comes off at 26.15 min. The GC scan alone
demonstrates that our sweat preparation method yielded quite a
few hydrophobic molecules, including cholesterol. In Figures 7–8,
we show two individual mass spectroscopy scans that focus on
molecular ranges around 270. Since some the odorous steroids
(e.g. androst-2-en-17-one MW 272.47, androsta-4,16,dien-3-one
MW 270, and androstenone MW 272.42) are in this range we
selected GC peaks that show m/z 270 and 272. Comparing the
mass spectra below to spectra of pure steroid compounds it is
apparent that we clearly have androgen steroids in our samples as
judged from the distribution of 270, 255 and 237 fragments and
272, 257 and 229 fragments [58]. The potential candidates for
these spectra are androstadienones (MW 272) and androstenones
(MW 270), which are of the class of compounds associated with
putative human reproductive pheromones, found in apocrine
sweat.
Release of semi-volatile components from aqueous
solutions. Many research olfactometers deliver odors by
bubbling air through a liquid containing the fragrance
molecules. In our study we paid particular attention to
optimizing the delivery of semi-volatile molecules because we
expect that a putative stress pheromone will be a steroid derivative
(such as androsta-4,16-dien-3-one). The physical chemistry of
vaporization of solutes in a typical olfactometer is straightforward.
While the bubbles travel through the solution the solutes partition
into the air and will be carried away [59]. The degree to which





where pair is the partial pressure of the solute in air, caqueous is the
concentration of the solute in water and H is the Henry’s law
constant. The concentration of a solute with Henry’s constant H in
a nebulizer will vary in time in the following way [59]:




where c0 is the initial concentration, G is the air flow rate, and V is
volume of the solution (in our case G=3 l/min and V=6 ml).
Henry’s law constants are usually estimated using the boiling point
of a substance and its aqueous solubility [60]. For androstenone
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partition coefficient of 0.012 is reported [61]. From that we can
estimate an exponential decay time for androstenone in our
nebulizer setup of about 10 seconds. For more realistic odorous
steroids with higher solubility (androst-2-en-17-one cS=2.3 mg/l,
androsta-4,16,dien-3-one cS=2.9 mg/l [62]) the release properties
of our setup (assuming that the partial vapor pressure stays constant)
the exponential decay time becomes about 100 seconds. For our
nebulizer parameters, and assuming a decay time of 100 seconds,
we deliver over the time of the experiment (50 seconds of air flow
through the nebulizer) about 40% of the semi-volatile solute.
The GCMS analysis of our sweat preparation and an estimation
of Henry’s law constants for candidate compounds for a stress
pheromone demonstrate that the sweat collection, aqueous
extraction, and delivery methods were capable of sampling over
hydrophobic pheromone-type compounds in human apocrine
sweat. In general, for an efficient delivery one needs to consider all
parameters in eq.2. The Henry’s law constant for a particular
solute can be adjusted by the choice of solvent. To deliver a
hydrophobic molecule, the Henry’s law constant is highest the
more water-like the solvent is. Other parameters that can be
adjusted are flow rate and the total volume. If one has fragrance
molecules in abundance, the best strategy is to have a long
exponential decay time which results in a nearly constant rate
delivery. In our case, since both the chemical nature of the
molecules and their concentration were unknown variables, we
chose the most efficient delivery though an aqueous solution.
Methods for Presenting Sweat Samples
For all experiments described here, the STRESS (test) and
EXERCISE (control) conditions were obtained from pooled sweat
obtained from the Donor stress and exercise conditions (described
above), respectively. The AIR condition was room air, which was
presented via the olfactometer as an additional control condition.
For both fMRI and behavioral experiments, all olfactory stimuli
were presented via a MRI compatible olfactometer of our own
design. The airflow control system was located outside the testing
room and was based upon a Lorig-design olfactometer [63]
ensuring that switching between six samples could be achieved
without change in flow velocity to the nostrils (<2.5 L/min). Five
sample lines and one constant air-flow line were fed into the testing
room and were connected to the nebulizer box close to the head of
the participant. The stimulus delivery was achieved through
nebulizing the aqueous sweat samples in commercially available
nebulizers close to the head of the participant. When pressurized,
the nebulizer creates a fine mist that rapidly releases semi-volatile
components from the aqueous solution into the air. We inserted
one-way valves between the nebulizers and the air-mixing manifold
to ensure that there was no odor leakage from nebulizers that were
not currently pressurized. After mixing of the constant air-flow line
(0.5 L/min) with air from one of the nebulizers in the manifold, the
air was delivered through a nasal cannula to the participant.
For both fMRI and behavioral studies, we employed breathing
cues synchronized to the delivery of the olfactometer. The
breathing cues were continuous throughout the experiment and
did not indicate the presence or absence of a condition, nor did
they distinguish between conditions. Since all stimuli were
delivered via a nasal cannula and we did not want to alert
participants that a condition was being presented, participants
were instructed and trained to breathe on cue and only through
their noses for the entire duration of the experiment.
For both fMRI studies, the cue was visual and presented on a
projected video screen within the scanner. This consisted of an
expanding and contracting ring (Figure 1a), which cued inhalation
and exhalation respectively. For the duration of the entire
experiments, breathing was paced to a 5 second cycle: 2.5 seconds
inhalation and 2.5 seconds exhalation, synchronized to the TR of
the scan (Figure 1b). In order to verifythat participantswere, in fact,
capable of complying with the breathing cues for the duration of the
experiment, for the first fMRI experiment we monitored breathing
in real time throughout the scan with a MR-compatible respiration
belt (Philips Medical Systems, N.A., Bothell, WA). Respiration data
were acquired at 500 Hz and noise was removed from the data
using a 5th order low-pass elliptic filter with a 2 Hz cutoff. Filtered
Figure 6. Gas chromatography mass spectroscopy analyses of exercise sweat samples were used to validate that our collection and
aqueous extraction methods were capable of sampling over hydrophobic (steroid) components in human apocrine sweat. Total ion
count gas chromatography trace of aqueous human sweat extract shows the presence of cholesterol, which is hydrophobic.
doi:10.1371/journal.pone.0006415.g006
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to calculate breathing rate and depth for each run. Because the
breathing cues that we used for the fMRI experiments were visual,
and therefore might have distracted from the visual task, for the
behavioral experiment we instead used auditory breathing cues to
synchronize inhalation with the olfactometer. Continuously in-
creasing and decreasing pitch, combined with a subtle rhythmic
element that conveyed time, signaled inhalation and exhalation
respectively. Respiratory compliance was monitored remotely
throughout the experiment (Biopac Systems, Goleta CA).
Validation of Trial-Specific Respiratory Parameters
To confirm compliance, we collected and analyzed respiratory
data from participants tested on the first fMRI study. Each of the
16 participants had a total of 6 runs, or 96 runs total. For
compliance to inhalation synchronization, 91.7% of all runs had
100% compliance to the breathing pattern, 4.2% had 95–99%
compliance, 2.1% had 90–94% compliance, and 2.1% had 85–
89% compliance. No run had less than 85% compliance.
Performing paired t-tests between test and control conditions,
there were no differences in respiratory compliance for either rate
(stress2exercise: t=21.03, p=0.32, N=16) or depth (stress2exercise:
t=20.81, p=0.43, N=16).
General Inclusion/Exclusion Criteria for Detector
Participants
The aim of the experiments was to investigate the effect of
STRESS vs. EXERICISE sweat on unrelated individuals
(‘‘Detectors’’). There was no overlap for the 144 Donor and 46
Detector participants, nor was there overlap, for either Donors or
Detectors, between either of the fMRI experiments and the
behavioral experiment. All potential Detector participants for the
fMRI, odor perception, and behavioral studies, were screened for
total or partial anosmia and nasal congestion using the University
of Pennsylvania Smell Identification Test (Psychological Assess-
ment Resources, Lutz FL). Due to the possible interactions
between hormonal changes and olfaction [64–67], female
participants were excluded if they were pregnant or lactating
and were not tested during menstruation; additionally, the Smell
Identification Test was administered prior to the scan because of
hormonal variability during the menstrual cycle.
Methods for fMRI Experiments
Original fMRI Experiment. Olfactory stimuli were
obtained from 40 male Donors. Detector participants were 16
males and females (50% female). Detector participants were
between the ages of 18 and 27 (m=22, s.d.=3), and were excluded
Figure 7. Gas chromatography mass spectroscopy analyses of exercise sweat samples were used to validate that our collection and
aqueous extraction methods were capable of sampling over hydrophobic (steroid) components in human apocrine sweat. Mass
spectrum of retention time 19.512 minutes shows the presence of human steroids found in apocrine sweat.
doi:10.1371/journal.pone.0006415.g007
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neurological illness, claustrophobia, or metal in the body.
Six runs of 104 repetitions (4:20) were performed. In each run,
there were six conditions presented (STRESS, EXERCISE, and
AIR), each presented once during continuously synchronized
closed-mouth nasal breathing and once during which the
participant was instructed to sniff. Our analyses showed that the
breathing and sniffing conditions generated very distinct time-
series, with sniffing producing quickly decaying time-courses more
typical of olfactory processing [69–71], and breathing producing
longer time-courses more similar to the standard 15–20 s
hemodynamic response function associated with non-olfactory
stimuli. The two conditions could not be analyzed together, since
the breathing conditions required analyses with a standard HRF
while the sniffing conditions required analyses with a short (5 s)
olfactory HRF [69]. Like the breathing condition, the sniffing
condition also significantly activated the amygdala (left amygdala
SVC: t=3.45/Z=2.92, puncorr=0.002, pcorr=0.08, N=16; ROI
superficial left amygdala t=2.27/Z=2.07, p=0.02, N=16; ROI
whole left amygdala t=2.10/Z=1.93, p=0.03, N=16; right
amygdala SVC: t=4.87/Z=3.71, puncorr=0.000, pcorr=0.03,
N=16; ROI superficial right amygdala t=0.81/Z=1.35,
p=0.22, N=16; ROI whole right amygdala T=1.41/Z=0.79,
p=0.09, N=16). In this paper we focus on the breathing
conditions, since their time-course is more clearly similar to those
produced by emotional, rather than olfactory, stimuli; a separate
article will address the sniffing conditions. Each odor period lasted
20 seconds (4 TR), with a 20 second gap between odor
presentations (REST). The orders of the six conditions were
pseudo-randomized in each of the six runs. Besides the visual
inhalation cues and three odor conditions (stress sweat, exercise
sweat, and air), no other stimuli were presented to participants
during the scans.
Participants were told that they might or might not smell odors
throughout the experiment. They had only one task; this was to
follow the breathing cues, which were continuous throughout the
experiment.
Data were acquired using a Philips 3T Achieva whole body
scanner (Philips Medical Systems, N.A., Bothell, WA) with an eight-
channel SENSE
TM head coil. After an initial localizer scan, a high
resolution T1-weighted MPRAGE3D anatomical image (TR/
TE=8.0/4.3 ms, flip angle=18u, FOV=25062506150 mm,
25662566168 matrix) was acquired for anatomical registration.
All fMRI data were collected as follows: single shot gradient echo
EPI, TR/TE=2500/22 ms, 96696 matrix, 2246224 mm FOV,
36 interleaved transverse slices (aligned to the AC-PC line) 3.5 mm
thick with no gap, 1 average, flip angle=83u. Iterative optimization
of all acquisition parameters prior to the experiment ensured that
Figure 8. Gas chromatography mass spectroscopy analyses of exercise sweat samples were used to validate that our collection and
aqueous extraction methods were capable of sampling over hydrophobic (steroid) components in human apocrine sweat. Mass
spectrum of retention time 20.655 minutes shows the presence of human steroids found in apocrine sweat.
doi:10.1371/journal.pone.0006415.g008
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of interest, the amygdala (left amygdala: 179.4; right amygdala: 175.0).
All image pre-processing for the analyses was implemented
using the SPM5 program (Wellcome Department of Cognitive
Neurology). For each participant’s GE-EPI dataset: 1) Data were
temporally shifted to correct for the order of slice acquisition, using
the first slice acquired in the TR as the reference. 2) All GE-EPI
images were realigned to each other. 3) The T1-weighted
(structural) image was co-registered to the first EPI volume using
a mutual information co-registration algorithm. 4) The co-
registered high-resolution image was used to determine parame-
ters (76867 non-linear basis functions) for transformation into a
Talairach standard space defined by the Montreal Neurologic
Institute template brain supplied with SPM5. 5) This transforma-
tion was applied to the GE-EPI data, which were re-sliced to
2m m 62m m 62 mm using 7
th degree polynomial approximation
to sinc-interpolation. 6) The spatially normalized GE-EPI data
were spatially smoothed with an isotropic Gaussian kernel (full-
width-at-half-maximum=6 mm).
The fMRI data analysis comprised two levels of voxel-wise
General Linear Models (GLMs). The first-level GLM is a
participant-separable time series analysis that yields summary
measures to be used in the second-level GLM, which affords
statistical inference at the population level. In the first-level GLM,
conditions were modeled with predictors comprising 20-second
duration boxcars convolved with the default hemodynamic
response function (HRF) of SPM5. A 0.2 Hz signal (to model
the breathing frequency), motion parameters and their squares
were included in the model as nuisance covariates. Linear
combinations of the estimated coefficients of these predictors
(i.e., contrasts) of interest were then computed per voxel per
participant. These contrasts were: (1) STRESS2EXERCISE; (2)
STRESS2AIR; and (3) EXERCISE2AIR. The first-level con-
trast images were used as the dependent variables into second-level
GLMs. For each contrast, we performed a second-level statistical
parametric mapping (SPM) test that was hypothesis-driven and
therefore restricted to the amygdala bilaterally. The threshold for
this test was obtained by using Gaussian random field small
volume correction (SVC), as implemented in SPM5, with the
search volumes defined by using the publicly available region of
interest library, the Anatomical Toolbox [72], for the amygdala
and its sub-divisions.
Replication fMRI Experiment
Olfactory stimuli were obtained from 40 Donors (50% female).
Detector participants were between the ages of 18 and 50 (m=26,
s.d.=3), and were excluded if they had a history of mental illness
or substance abuse [68], neurological illness, claustrophobia, or
metal in the body.
Based upon our results from the previous fMRI experiment, we
had participants breathe continuously throughout this experiment,
with no sniffing conditions; this significantly increased statistical
power by effectively doubling the number of trials we could obtain
from the same amount of sweat. Four runs of 144 repetitions (6:00)
were performed. In each run, there were three conditions
presented (STRESS, EXERCISE, and AIR). STRESS and
EXERCISE were each presented four times; air was presented
between each of the conditions (REST), as well as once at the end
of each run as a separate condition (AIR). Since we wanted to
determine whether there were gender effects, either for donor sex,
detector sex, or donor*detector sex, in half of the STRESS
conditions we used male donor stress sweat, and in the other half
we used female donor stress sweat, with runs counter-balanced for
order between participants. Each odor period lasted 20 seconds (4
TR), with a 20 second gap between odor presentations (REST),
identical to the AIR condition. Besides the visual inhalation cues
and three odor conditions (stress sweat, exercise sweat, and air), no
other stimuli were presented to participants during the scans.
Data were acquired using a Siemens 3T Trio whole body
scanner (Siemens Medical Systems, Malvern, PA) with a circularly
polarized T/R head coil. After an initial localizer scan, a high
resolution (T1 weighted MPRAGE3D, resolution (RL, AP, SI) of
1.336161 mm (TI=1100, TR/TE=2100/2.74, a=120,
FOV=17062566256 mm, 12862566256 pixels, total imaging
time 8:59) was acquired for anatomical registration. All fMRI data
were collected as follows: single shot gradient echo EPI, TR/
TE=2500/30 ms, 64664 matrix, 2246224 mm FOV, 26
interleaved transverse slices (aligned to the AC-PC line) 3.5 mm
thick with no gap, 1 average, flip angle=83u.
The fMRI data were pre-processed and statistically analyzed as
described in the original experiment.
Methods for Odor-Perception Experiments
Assessment of Odor Intensity and Valence. Olfactory
stimuli were obtained from the 80 Donors (25% female) who
provided samples for the two fMRI experiments. Detector
participants were the last 10 participants who participated in the
first fMRI experiment, as well as the 16 participants who
participated in the second fMRI experiment (N=26, 50%
female). Immediately following the fMRI acquisition, we
performed structured assessments of odor perception; both
participants and researchers were blind to vial contents, and
conditions were presented randomly. Participants were provided
the vials one at a time and asked to rate them individually for
strength and pleasantness on Likert scales between 0 (no detectable
odor/extremely pleasant) to 10 (extremely strong odor/extremely
unpleasant). Scores for all three stress-sweat vials and all three
exercise-sweat vials were averaged for the statistical analyses,
which used non-parametric Wilcoxon Sign-Ranks tests.
Forced Choice Odor-Discrimination Task. Olfactory
stimuli were obtained from the 64 Donors (50% female) who
provided samples for the behavioral study. Detector participants
were 14 individuals who participated in the behavioral
experiment, as well as an additional two individuals (N=16,
50% female; mage=24, s.d.=5). Each participant received 16
discrimination trials in a same-different paradigm, with 8 different-
odor pairs and 8 same-odor pairs presented in random order. The
odorants were fragrance paper strips dipped for three seconds in
either stress sweat or exercise sweat. The participants were told
that they would be presented with two substances for each trial,
and were instructed to indicate whether the odorants smelled ‘‘the
same or different.’’ The paired odorants in each trial were
presented in quick succession within an interval of a few seconds.
A minimum of 10 seconds was allowed between trials. Participants
were allowed to sniff only once for each presentation and were
then required to respond either ‘‘same’’ or ‘‘different’’, or to guess
if unsure. No feedback was given as to the correctness of the
response; the odor assessment was performed with both
participant and researcher blind to condition. Accuracy scores
were computed for each participant, and statistically compared to
chance (50%) using a one-sample t-test.
Methods for Behavioral Experiment
Olfactory stimuli were obtained from 64 Donors (50% female).
Detector participants were 14 individuals (5 female; mage=23,
SD=5) with no history of mental illness, substance abuse [68], or
neurological illness. All visual stimuli were obtained from the
Pictures of Facial Affect (Paul Ekman Inc., Oakland CA). Using
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ing, Moscow Russia), we produced nine levels of morph (10%–
90%) equally distributed between the Neutral (0%) and Angry
(100%) poles. Pilot testing prior to the experiment (N=8, 50%
female) established reliability curves for all faces in the set; from
these we selected the three faces (EM, JJ, PE; all male) that,
without olfactory stimuli, most reliably produced classically-
psychometric responses along morph levels. All visual stimuli
were presented on a 42-inch plasma screen situated 6 feet from the
participant, in an otherwise dark and silent audiometric chamber.
As illustrated by Figure 5a, each trial consisted of a 500 ms of rest,
2500 ms of inhalation, a brief stimulus-on period (200 ms), 500 ms
of rest, and 2500 ms of exhalation (total of 5700 ms per trial). Pilot
studies with 4,16-androstadien-3-one, oestra-1,3,5(10),16-tetraen-
3-ol, as well as common odorants, were conducted prior to the
experiment in order to optimize experimental parameters; these
were set at 14 trials per 9 morph levels, with morph levels and
faces chosen randomly for each trial. These 126 trials (1469
morph levels) were presented under two conditions: while
breathing stress sweat (STRESS), and while breathing exercise
sweat (EXERCISE). The total experiment ran for 28 minutes. To
maximize participant compliance and focus throughout the
experiment, testing was divided up into four seven-minute runs:
two for the STRESS condition, and two for the EXERCISE
condition, with two minutes between runs. STRESS and
EXERCISE conditions alternated for each participant, with
condition order counter-balanced between participants.
Participants were instructed to indicate, following presentation
of the facial stimuli, whether the face was ‘‘more neutral or more
threatening.’’ Participants used a two-button computer mouse to
make their choice, and were asked to do so as quickly as possible
without making errors. Limits were set so that responses were not
accepted after 2500 ms post-presentation; responses provided in
fewer than 200 ms were excluded.
Each individual participated in 5 minutes of training prior to the
experiment. Participants first practiced following the auditory
breathing cues alone, using only room air. Participants then
practiced only using the mouse to identify the faces as neutral or
threatening. For the practice sessions, we used 0% angry and
100% angry poles for the three faces presented in the experiment;
this served to perceptually ‘‘fix’’ the endpoints for the psychomet-
ric curves for all participants. Finally, after mastering both of these
components, participants combined them to practice the behav-
ioral task with the breathing cues, again using only 0% and 100%
angry faces and room air.
This experiment was optimized for psychometric curve-fitting, a
method often employed to exploit the instability linked to
ambiguous stimuli in order to test subtle shifts in perception
induced by an external manipulation [73]. For each participant,




1ze{s A{A0 ðÞ ð3Þ
where p0 and p0+Dp define upper and lower asymptotes, A0 was
the inflection point, and s defined slope. The fitting was done
using curve-fitting toolbox packaged with Matlab 7.4.0. (Math-
works, Natick MA). This function provided a natural fit to the data
with a mean R
2 value of 0.9860.02, as compared to a simple
linear fit with mean R
2 value of 0.8960.06. Statistical tests
(repeated-measures ANOVA) were then performed on individual
inflection points and slopes for each participant to assess changes
in perceptual threshold and discrimination, respectively.
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